Showing results (731-740 of 4,871) with videos related to
Sort By:
Pageof 488
Urologic Oncology|May 6, 2009
Clinical implications of hypoxia inducible factor in renal cell carcinomaMarc C Smaldone, Jodi K MaranchieUrologic Oncology|May 6, 2009
Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent diseaseElahe A Mostaghel, Bruce Montgomery, Peter S NelsonUrologic Oncology|May 6, 2009
Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimensSusan KasperUrologic Oncology|May 6, 2009
Rethinking the central dogma: noncoding RNAs are biologically relevantVictoria L RobinsonUrologic Oncology|June 16, 2009
Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancerMichael Seitz, Christian Gratzke, Boris Schlenker, et al.Urologic Oncology|June 27, 2009
Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic featuresUgo De Giorgi, Giovanni Rosti, Roberto Salvioni, et al.Urologic Oncology|June 27, 2009
Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removedIn Gab Jeong, Jinsung Park, Kanghyon Song, et al.Urologic Oncology|July 7, 2009
A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?Raj Kurpad, William Kim, W Kim Rathmell, et al.Urologic Oncology|July 7, 2009
Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancerSatoshi Anai, Noboru Sakamoto, Yoshihisa Sakai, et al.Urologic Oncology|January 2, 2009
Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancerSabrina Thalita dos Reis, Fabiola Elizabeth Villanova, Priscila Maria Andrade, et al.Pageof 488